STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women

NACompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

May 15, 2016

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
HIV PreventionSexually Transmitted Diseases
Interventions
DIAGNOSTIC_TEST

Point-of-care STI testing

All participants underwent point-of-care STI testing (GeneXpert), and if diagnosed with a STI were offered immediate therapy, and expedited therapy, if indicated.

Trial Locations (1)

4001

CAPRISA, Durban

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Centre for the AIDS Programme of Research in South Africa

NETWORK

NCT03407586 - STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women | Biotech Hunter | Biotech Hunter